Topics

New eTheRNA led international consortium to develop COV-2 mRNA vaccineCV-19

09:53 EDT 24 Mar 2020 | Manufacturing Chemist

eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for high risk populations

Original Article: New eTheRNA led international consortium to develop COV-2 mRNA vaccineCV-19

NEXT ARTICLE

More From BioPortfolio on "New eTheRNA led international consortium to develop COV-2 mRNA vaccineCV-19"

Quick Search

Relevant Topic

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...